Status:
COMPLETED
Treatment of Androgenetic Alopecia in Males and Females
Lead Sponsor:
Apira Science, Inc.
Conditions:
Androgenetic Alopecia
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the efficacy of Low Level Laser and Light Therapy system configured in a novel product called the TopHat 655 system, for promoting hair growth in males and fem...
Eligibility Criteria
Inclusion
- Diagnosis of androgenetic alopecia
- Fitzpatrick Skin Phototypes I-IV
- Norwood-Hamilton IIa to V for males and Ludwig I or II for females
- Active hair loss within the last 12 months
- Willingness to refrain from using all other hair growth products or treatments
- In overall general good health as determined by the physician investigator
Exclusion
- Photosensitivity to laser light and non-laser LED light operating at 655nms.
- Malignancy in the target treatment area
- Other forms of alopecia of the head
- Past medical history of a collagen-vascular disease, thyroid disease or other cutaneous or systemic disease that seriously effects the scalp
- Unwillingness to remove hair replacement products during the therapy sessions
- Using any medications deemed to inhibit hair growth as determined by the physician investigator
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT01437163
Start Date
September 1 2011
End Date
August 1 2013
Last Update
July 12 2016
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Adolfo Fernandez-Obregon, MD
Hoboken, New Jersey, United States, 07030
2
Peter S. Halperin, MD
New York, New York, United States, 10065
3
Raymond J. Lanzafame, MD
Rochester, New York, United States, 14617
4
Jeffrey A. Sklar, MD
Woodbury, New York, United States, 11797